Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway

Lulu Liang; Xiaochen Wang; Baier Sun; Yipeng Sun; Jing Chen; Jiebang Jiang; Meng Li; Sisi He; Rongpeng Li; Fei Wang

doi:10.1016/j.bcp.2025.117628

Affiliated Institutions

Related Publications

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with <i>In vitro</i> and <i>In vivo</i> Antitumor Activity

Christine M. Chresta , Barry R. Davies , Ian Hickson +21 more

Abstract The mammalian target of rapamycin (mTOR) kinase forms two multiprotein complexes, mTORC1 and mTORC2, which regulate cell growth, cell survival, and autophagy. Allosteri...

2009 Cancer Research 780 citations

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

James Brugarolas , Kui Lei , Rebecca L. Hurley +6 more

Mammalian target of rapamycin (mTOR) is a central regulator of protein synthesis whose activity is modulated by a variety of signals. Energy depletion and hypoxia result in mTOR...

2004 Genes & Development 1348 citations

Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt

Henryk Dudek , Sandeep Robert Datta , Thomas Franke +6 more

A signaling pathway was delineated by which insulin-like growth factor 1 (IGF-1) promotes the survival of cerebellar neurons. IGF-1 activation of phosphoinositide 3-kinase (PI3-...

1997 Science 2444 citations

Autophagy and autophagy-related proteins in cancer

Xiaohua Li , Shikun He , Binyun Ma

Autophagy, as a type II programmed cell death, plays crucial roles with autophagy-related (ATG) proteins in cancer. Up to now, the dual role of autophagy both in cancer progress...

2020 Molecular Cancer 1494 citations

Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

Gregory J. Brunn , Christine C. Hudson , Aleksandar Sekulić +5 more

The immunosuppressant rapamycin interferes with G 1 -phase progression in lymphoid and other cell types by inhibiting the function of the mammalian target of rapamycin (mTOR). m...

1997 Science 956 citations

Publication Info

Year: 2025
Type: article
Volume: 245
Pages: 117628-117628
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Lulu Liang, 
                                
                                    Xiaochen Wang, 
                                
                                    Baier Sun
                                
                                et al.
                            
                            (2025). 
                            Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway. 
                            Biochemical Pharmacology
                            , 245
                            
                            , 117628-117628.
                            https://doi.org/10.1016/j.bcp.2025.117628

Identifiers

DOI: 10.1016/j.bcp.2025.117628